Medicine & TechnologyResearch showed that pregnant and lactating mothers have better protection against COVID-19 with antibodies they can pass on to their newborns.
Large clinical trial results have revealed that the AstraZeneca COVID-19 vaccine is well-tolerated and it shields from symptomatic COVID-19 injection, including severe disease or hospital confinement.
Oravax, a pharmaceutical company, is developing an oral COVID-19 vaccine that would be easier to store, ship, and administer as compared to commonly used intravenous vaccines.
Experts say that a vaccine that could prevent hospitalization, reduce mortality, and halt the spread of asymptomatic infections holds the key to finally halting and containing COVID-19.
A preprint study confirms the first confirmed case of a baby born with COVID-19 antibodies after the mother gets vaccinated when she was 36 weeks pregnant.
Moderna announced COVID-19 vaccine trials on children 6 months to 12 years old to study the vaccine jab's safety and effectiveness on pediatric patients.
A new scientific report reviews the role nanotechnology plays in the ongoing fight against the novel coronavirus, examining its role in diagnosing and curing the highly-contagious COVID-19.
AstraZeneca announced it had reviewed more than 17 million individuals who got their COVID-19 vaccine in the EU and UK, and the result did not show any evidence of increased risks of blood clots.
Three countries namely Denmark, Norway, and Iceland temporarily suspended the administration of the AstraZeneca COVID-19 vaccine after reports of blood clot formations in some individuals who got their vaccines.
Researchers have developed a potential new nanoparticle-delivered COVID-19 vaccine that has presented strong effectiveness in preclinical illness models.
Most data on Pfizer's efficacy of COVID-19 vaccines have come under controlled conditions in clinical trials. However, a new claims the vaccine is likely a strong protective benefit against infection